Sawyer EJ - Search Results

1

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

Couch FJ, Kuchenbaecker KB, Michailidou K, Mendoza-Fandino GA, Nord S, Lilyquist J, Olswold C, Hallberg E, Agata S, Ahsan H, Aittomäki K, Ambrosone C, Andrulis IL, Anton-Culver H, Arndt V, Arun BK, Arver B, Barile M, Barkardottir RB, Barrowdale D, Beckmann L, Beckmann MW, Benitez J, Blank SV, Blomqvist C, Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Brauch H, Brenner H, Burwinkel B, Buys SS, Caldes T, Caligo MA, Canzian F, Carpenter J, Chang-Claude J, Chanock SJ, Chung WK, Claes KB, Cox A, Cross SS, Cunningham JM, Czene K, Daly MB, Damiola F, Darabi H, de la Hoya M, Devilee P, Diez O, Ding YC, Dolcetti R, Domchek SM, Dorfling CM, Dos-Santos-Silva I, Dumont M, Dunning AM, Eccles DM, Ehrencrona H, Ekici AB, Eliassen H, Ellis S, Fasching PA, Figueroa J, Flesch-Janys D, Försti A, Fostira F, Foulkes WD, Friebel T, Friedman E, Frost D, Gabrielson M, Gammon MD, Ganz PA, Gapstur SM, Garber J, Gaudet MM, Gayther SA, Gerdes AM, Ghoussaini M, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Gronwald J, Guénel P, Gunter M, Haeberle L, Haiman CA, Hamann U, Hansen TV, Hart S, Healey S, Heikkinen T, Henderson BE, Herzog J, Hogervorst FB, Hollestelle A, Hoon… See abstract for full author list ➔ Couch FJ, et al. Among authors: sawyer ej. Nat Commun. 2016 Apr 27;7:11375. doi: 10.1038/ncomms11375. Nat Commun. 2016. PMID: 27117709 Free PMC article.

2

Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components.

Sawyer EJ, Hanby AM, Ellis P, Lakhani SR, Ellis IO, Boyle S, Tomlinson IP. Sawyer EJ, et al. Am J Pathol. 2000 Mar;156(3):1093-8. doi: 10.1016/S0002-9440(10)64977-2. Am J Pathol. 2000. PMID: 10702425 Free PMC article.

3

The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours.

Sawyer EJ, Hanby AM, Rowan AJ, Gillett CE, Thomas RE, Poulsom R, Lakhani SR, Ellis IO, Ellis P, Tomlinson IP. Sawyer EJ, et al. J Pathol. 2002 Apr;196(4):437-44. doi: 10.1002/path.1067. J Pathol. 2002. PMID: 11920740

4

Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.

Sawyer EJ, Poulsom R, Hunt FT, Jeffery R, Elia G, Ellis IO, Ellis P, Tomlinson IP, Hanby AM. Sawyer EJ, et al. J Pathol. 2003 May;200(1):59-64. doi: 10.1002/path.1318. J Pathol. 2003. PMID: 12692842

5

MSI-low, a real phenomenon which varies in frequency among cancer types.

Halford SE, Sawyer EJ, Lambros MB, Gorman P, Macdonald ND, Talbot IC, Foulkes WD, Gillett CE, Barnes DM, Akslen LA, Lee K, Jacobs IJ, Hanby AM, Ganesan TS, Salvesen HB, Bodmer WF, Tomlinson IP, Roylance RR. Halford SE, et al. Among authors: sawyer ej. J Pathol. 2003 Nov;201(3):389-94. doi: 10.1002/path.1453. J Pathol. 2003. PMID: 14595750

6

O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C>A:T transitions.

Halford S, Rowan A, Sawyer E, Talbot I, Tomlinson I. Halford S, et al. Gut. 2005 Jun;54(6):797-802. doi: 10.1136/gut.2004.059535. Gut. 2005. PMID: 15888787 Free PMC article.

7

A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence.

Jones AM, Mitter R, Springall R, Graham T, Winter E, Gillett C, Hanby AM, Tomlinson IP, Sawyer EJ; Phyllodes Tumour Consortium. Jones AM, et al. Among authors: sawyer ej. J Pathol. 2008 Apr;214(5):533-44. doi: 10.1002/path.2320. J Pathol. 2008. PMID: 18288784

8

mRNA expression profiling of phyllodes tumours of the breast: identification of genes important in the development of borderline and malignant phyllodes tumours.

Jones AM, Mitter R, Poulsom R, Gillett C, Hanby AM, Tomlinson IP, Sawyer EJ; Phyllodes Tumour Consortium. Jones AM, et al. Among authors: sawyer ej. J Pathol. 2008 Dec;216(4):408-17. doi: 10.1002/path.2439. J Pathol. 2008. PMID: 18937276

9

Low penetrance breast cancer predisposition SNPs are site specific.

Mcinerney N, Colleran G, Rowan A, Walther A, Barclay E, Spain S, Jones AM, Tuohy S, Curran C, Miller N, Kerin M, Tomlinson I, Sawyer E. Mcinerney N, et al. Breast Cancer Res Treat. 2009 Sep;117(1):151-9. doi: 10.1007/s10549-008-0235-7. Epub 2008 Nov 13. Breast Cancer Res Treat. 2009. PMID: 19005751

10

The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer.

Colleran G, McInerney N, Rowan A, Barclay E, Jones AM, Curran C, Miller N, Kerin M, Tomlinson I, Sawyer E. Colleran G, et al. Breast Cancer Res Treat. 2010 Jan;119(2):437-42. doi: 10.1007/s10549-009-0395-0. Epub 2009 Apr 24. Breast Cancer Res Treat. 2010. PMID: 19390964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page